AbbVie (ABBV) reports positive phase 1 multiple ascending dose results for ABBV-295, a long-acting amylin analog
Newsquawk Staff ·
AbbVie (ABBV) reports positive phase 1 multiple ascending dose results for ABBV-295, a long-acting amylin analog.
What it means
AbbVie's positive phase 1 results for ABBV-295 indicate strong potential for its long-acting amylin analog, suggesting a promising addition to their pipeline, particularly in the diabetes space. This could positively impact investor sentiment and drive stock performance, especially as the market evaluates future revenue contributions from new therapies in their portfolio.
Sources
- Canada's Competition Bureau says proposed arrangements between Air Canada and United Airlines (UAL) would lead to higher prices, with the Transport Minister set to review the findings of its investigation
- JPMorgan Chase (JPM) reportedly faces an additional GBP 100-150mln tax bill following the UK government's decision to double the corporation tax surcharge on banks, potentially jeopardising plans for its new London headquarters, Sky News reports
- US EQUITY OPEN: Indices rangebound ahead of FOMC and major earnings
- Daily US Conference Calendar - 28th October 2026: JNJ, BA, CAT
- Biogen Inc. (BIIB) Q3 2026 (USD): Adj. EPS 2.62 (exp. 1.98), Revenue 2.8bln (exp. 2.63bln). Raises lower end of FY26 diluted EPS guidance to USD 12.20-13.00 (exp. 12.23, prev. 12.00-13.00)
Related headlines
- Verisk (VRSK) integrates insurance intelligence with Amazon (AMZN) and Microsoft (MSFT) AI platforms1 hour ago
- Senior US Treasury trade official Eric Ettorre will leave to join Netflix (NFLX), reports Axios1 hour ago
- T-Mobile (TMUS) CEO to step down from the board1 hour ago
- US PRE-MARKET MOVERS: SKHY, NXPI, ENPH, APH, GOOGL, HOOD, PPG, VRT, GEV, GEHC, BSX, ETSY, WEN, V2 hours ago
- US Broker Moves: ENPH and DYN downgraded at Oppenheimer; FFIV downgraded at Piper Sandler2 hours ago
- Amphenol (APH) Q3 2026 (USD): Adj. EPS 0.80 (exp. 0.73), Sales 10.2bln (exp. 9.49bln)2 hours ago
- GE Vernova (GEV) expects USD 50-100mln of annual cost synergies from Trench by 2030, according to the conference call3 hours ago
- Etsy Inc. (ETSY) Q3 2026 (USD): EPS 1.00 (exp. 0.77), Revenue 692mln (exp. 668mln)3 hours ago
- Etsy (ETSY) CFO Baker is to leave on March 1st 2027, will remain an advisor through July 1st 20273 hours ago
- Garmin Ltd. (GRMN) Q3 2026 (USD): Adj. EPS 2.76 (exp. 2.41), Revenue 1.99bln (exp. 1.99bln)3 hours ago
- Phillips 66 (PSX) Q3 2026 (USD): Adj. EPS 14.08 (exp. 11.73)4 hours ago
- Aon (AON) Q3 (USD): Adj. EPS 3.36 (exp. 3.30), Revenue 4.1bln (exp. 4.08bln)4 hours ago
- GE Healthcare Technologies Inc. (GEHC) Q3 (USD): Adj. EPS 1.34 (exp. 1.20), Revenue 5.5bln (exp. 5.35bln), Adj. EBIT 913mln (exp. 838.8mln)4 hours ago
- GE Vernova Inc. (GEV) Q3 (USD) Revenue 12.6bln (exp. 11.99bln), Adj. EBITDA 1.9bln (exp. 1.69bln). Current FY Rev. 46-5-47.5bln (exp. 46.33bln)4 hours ago
- GE Vernova (GEV) to acquire Trench Group for USD 9bln4 hours ago